Thyrocare Technologies Limited (THYROCARE) - Total Liabilities
Based on the latest financial reports, Thyrocare Technologies Limited (THYROCARE) has total liabilities worth Rs1.46 Billion INR (≈ $15.80 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Thyrocare Technologies Limited cash flow conversion to assess how effectively this company generates cash.
Thyrocare Technologies Limited - Total Liabilities Trend (2011–2025)
This chart illustrates how Thyrocare Technologies Limited's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Thyrocare Technologies Limited's assets to evaluate the company's liquid asset resilience ratio.
Thyrocare Technologies Limited Competitors by Total Liabilities
The table below lists competitors of Thyrocare Technologies Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hektas Ticaret TAS
IS:HEKTS
|
Turkey | TL12.52 Billion |
|
Guangdong Mingzhu Group Co Ltd
SHG:600382
|
China | CN¥553.28 Million |
|
Jiangsu Rainbow Heavy Industries Co Ltd
SHE:002483
|
China | CN¥7.53 Billion |
|
Limbach Holdings Inc
NASDAQ:LMB
|
USA | $185.47 Million |
|
Life Healthcare
JSE:LHC
|
South Africa | ZAC13.55 Billion |
|
Chongqing Pharscin Pharmaceutical Co Ltd
SHE:002907
|
China | CN¥287.66 Million |
|
GMR Power and Urban Infra Limited
NSE:GMRP&UI
|
India | Rs150.30 Billion |
Liability Composition Analysis (2011–2025)
This chart breaks down Thyrocare Technologies Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see THYROCARE stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.65 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.26 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Thyrocare Technologies Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Thyrocare Technologies Limited (2011–2025)
The table below shows the annual total liabilities of Thyrocare Technologies Limited from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs1.46 Billion ≈ $15.76 Million |
+25.33% |
| 2024-03-31 | Rs1.16 Billion ≈ $12.57 Million |
+19.23% |
| 2023-03-31 | Rs975.00 Million ≈ $10.54 Million |
+20.24% |
| 2022-03-31 | Rs810.90 Million ≈ $8.77 Million |
-31.58% |
| 2021-03-31 | Rs1.19 Billion ≈ $12.82 Million |
+15.44% |
| 2020-03-31 | Rs1.03 Billion ≈ $11.10 Million |
+159.27% |
| 2019-03-31 | Rs396.00 Million ≈ $4.28 Million |
+10.94% |
| 2018-03-31 | Rs356.96 Million ≈ $3.86 Million |
+23.00% |
| 2017-03-31 | Rs290.22 Million ≈ $3.14 Million |
-34.14% |
| 2016-03-31 | Rs440.64 Million ≈ $4.77 Million |
+133.28% |
| 2015-03-31 | Rs188.89 Million ≈ $2.04 Million |
-52.14% |
| 2014-03-31 | Rs394.68 Million ≈ $4.27 Million |
+8.35% |
| 2013-03-31 | Rs364.28 Million ≈ $3.94 Million |
+5.28% |
| 2012-03-31 | Rs346.01 Million ≈ $3.74 Million |
+3.56% |
| 2011-03-31 | Rs334.11 Million ≈ $3.61 Million |
-- |
About Thyrocare Technologies Limited
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology. The Imaging Services segment sells radio-pharmaceutical an… Read more